Richard Johnson Chief Executive Officer and President, Parenteral Drug Association Martin VanTrieste Immediate Past Chair, Parenteral Drug Association Andy Skibo Head of Global Biologics Operations & Global Engineering, AstraZeneca/Medimmune Michael W. Vandiver Vice President of Manufacturing & Plant Design, Just Biotherapeutics Rino Rappuoli Chief Scientist and Head External R&D, GSK Vaccines Gil Roth President, Pharma & Biopharma Outsourcing Association John Bournas President and Chief Executive officer, ISPE Cornell Stamoran Vice President, Catalent Jim Breen Vice President, Worldwide Engineering and Technical Operations, Johnson & Johnson Moncef Slaoui Partner, Medicxi James Agalloco President, Agalloco & Associates Harold Baseman Chief Operating Officer, ValSource Gary Cunnington Global Head of CTSU Business Consultancy, Boehringer Ingelheim Madhavan (Madhu) Balachandran Business Owner, mjb Consultants Marc Bisschops Director Continuous Bioprocessing, Pall Biotech Miguel Forte Chief Executive Officer, Zelluna Immunotherapy and Chief Commercialization Officer and Chair of Commercialization Committee, International Society of Cellular Therapy Fiona Greer Global Director, BioPharma Services Development, SGS Ajaz Hussain Founder and Chief Executive Officer, Insight, Advice and Solutions; President, National Institute for Pharmaceutical Technology and Education Maik Jornitz Chief Executive Officer, G-Con Manufacturing Carol Lynch President Sandoz Inc and Head of North America Daniel O’Connor Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency Guido Rasi Executive Director, European Medicines Agency Ram Sasisekharan Alfred H. Caspary Professor of Biological Engineering and Health Sciences & Technology, MIT Department of Biological Engineering Thomas Ryll Vice President of Technical Operations, Immunogen Andrew Witty Chief Executive, Optum (effective July 1, 2018)
